Use of Hantzsch reaction for quantitation of milnacipran as a magic treatment for fibromyalgia syndrome in human plasma and urine.
Islam M MostafaMahmoud A OmarDalia M NagySayed M DerayeaPublished in: Luminescence : the journal of biological and chemical luminescence (2020)
A new fluorimetric procedure is described for analysis of milnacipran in its bulk, tablet dosage forms, as well as in biological human samples such as plasma and urine. The suggested method relies on the construction of a derivative with strong fluorescence called dihydropyridine derivative. This derivative resulted from the interaction of the primary amino group in the studied drug and acetylacetone/formaldehyde in McIlvaine buffer (pH 5). The fluorescent dihydropyridine derivative was measured at 470 nm. Influences of experimental variables namely pH, reagent concentration and temperature were examined and optimized. The calibration curve showed linearity over the range of 0.15-1.25 μg ml-1 of milnacipran with an R2 value of 0.9998. The detection limit was 0.02 μg ml-1 and the determination limit was 0.07 μg ml-1 . The developed procedure was successfully used in the assay of the studied drug in Avermilan® tablets with excellent selectivity. In addition, the reaction was applied to estimate the drug in spiked human plasma and urine with mean percentage recoveries of 100.04 ± 1.61 and 99.78 ± 0.81% for urine and plasma, respectively.
Keyphrases
- endothelial cells
- water soluble
- minimally invasive
- adverse drug
- ms ms
- mass spectrometry
- high throughput
- emergency department
- solid phase extraction
- quantum dots
- drug induced
- label free
- solid state
- case report
- liquid chromatography tandem mass spectrometry
- single molecule
- photodynamic therapy
- living cells
- electronic health record
- high resolution
- replacement therapy
- liquid chromatography
- high performance liquid chromatography
- real time pcr
- low cost
- ionic liquid
- pluripotent stem cells